background image

Regeneron Pharmaceuticals Clinical Trials

Find clinical trials for Regeneron Pharmaceuticals. Search for Regeneron Pharmaceuticals clinical trials in different cities and states across the United States.

Filter
Active & Responsive

A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants, Adolescents and Adults With Hearing Loss Due to Otoferlin Mutations

for
Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF),
Location: Boston MA, New York NY, Orlando FL, Jacksonville FL,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 0+

Code: NCT05788536

Phase1, Phase2, Recruiting
New

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

for
Atrial Fibrillation (AF)
Location: Dothan AL, Pensacola FL, West Monroe LA, Houston TX,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07626411

Phase3, Recruiting
New

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

for
Overweight or Obesity
Location: Maitland FL, Winter Park FL, The Villages FL,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07685808

Phase2, Recruiting
New

A Study to Evaluate the Efficacy and Safety of Fel d 1 Monoclonal Antibodies in Adult and Pediatric Participants With Allergic Conjunctivitis Due to Cat Allergy

for
Allergic Conjunctivitis
Location: Andover MA
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 8+

Code: NCT07675811

Phase3, Recruiting
New

REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma

for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: Zion IL, Houston TX, Goodyear AZ, Duarte CA
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07594106

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment With Pozelimab + Cemdisiran Combination Therapy is and How Well it Works

for
Paroxysmal Nocturnal Hemoglobinuria
Location: Toronto
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05744921

Phase3, Recruiting

A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma

for
Relapsed Refractory Multiple Myeloma (RRMM)
Location: Durham NC
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05730036

Phase3, Recruiting

An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)

for
Adverse Pregnancy Outcomes, Atopic Dermatitis
Location: Boston MA
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18 - 49

Code: NCT03936335

Recruiting

A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

for
Monoclonal Gammopathy of Undetermined Significance (MGUS),
Location: Boston MA, Stony Brook NY, New York NY, Philadelphia PA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06140524

Phase2, Recruiting

Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: New York NY, Tampa FL, Columbus OH, Atlanta GA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT03761108

Phase1, Phase2, Recruiting